典型文献
Treatment of Chronic Aplastic Anemia with Chinese Patent Medicine Pai-Neng-Da Capsule for Replacing Androgen Partially:A Clinical Multicenter Study
文献摘要：
Objective:To evaluate the efficacy and safety of Pai-Neng-Da Capsule (panaxadiol saponins component,PNDC) in combination with the cyclosporine and androgen for patients with chronic aplastic anemia (CAA).Methods:A total of 79 CAA patients was randomly divided into 2 groups by a random number table,including PCA group[43 cases,orally PNDC 320 mg/d plus cyclosporine 5 mg/(kg·d) plus andriol 80 mg/d]and CA group[36 cases,orally cyclosporine 5 mg/(kg·d) plus andriol 160 mg/d].All patients were treated and followed-up for 6 treatment courses over 24 weeks.The complete blood counts,score of Chinese medical (CM) symptoms were assessed and urine routine,electrocardiogram,hepatic and renal function were observed for safety evaluation.Female masculinization rating scale was established according to the actual clinical manifestations to evaluate the accurate degree of masculinization in female CAA patients treated by andriol.Results:The effective rates were 88.1％ (37/42) in the PCA group and 77.8％ (28/36) in the CA group based on the standard for the therapeutic efficacy evaluation of hematopathy.There was no significant difference in the white blood cell (WBC) counts,platelet counts and hemoglobin concentration of peripheral blood between two groups after 6 months treatment.The masculinization score of female patient in the PCA group was significantly lower than the CA group (P＜0.05).The mild abdominal distention was observed in 1 case in the PCA group.In CA group,the abnormalities in the hepatic function developed in 2 cases and the renal disfunction was found in 1 case.Conclusion:The PNDC possesses certain curative effects in the treatment of CAA without obvious side-effects and can partially replace andriol thereby to reduce the degree of masculinization[Registried at Chinese Clinical Trial Registry (ChicTR1900028153)].
文献关键词：
中图分类号：
作者姓名：
JIANG Zhi-yong;YU Fang-quan;GAO Rui-lan;KUANG Yue-min;ZHU Yan;CHEN Yue-hua;LI Lin-jie;OUYANG Gui-fang;HU Jing;WU Xiao-long
作者机构：
Department of Hematology,Jinhua People's Hospital,Jinhua 321000 ,Zhejiang Province,China;Institute of Hematology Research,the First Affiliated Hospital of Zhejiang Chinese Medical University,Hangzhou 310006 ,China;Department of Hematology,the Second of Shaoxing Hospital,Shaoxing 312000 ,Zhejiang Province,China;Department of Hematology,Lishui Central Hospital,Lishui 323000 ,Zhejiang Province,China;Department of Hematology,First Hospital of Ningbo,Ningbo 315010 ,Zhejiang Province,China;Department of Clinical Medicine,Medical College,Jinhua Polytechnic,Jinhua 321000 ,Zhejiang Province,China
文献出处：
引用格式：
[1]JIANG Zhi-yong;YU Fang-quan;GAO Rui-lan;KUANG Yue-min;ZHU Yan;CHEN Yue-hua;LI Lin-jie;OUYANG Gui-fang;HU Jing;WU Xiao-long-.Treatment of Chronic Aplastic Anemia with Chinese Patent Medicine Pai-Neng-Da Capsule for Replacing Androgen Partially:A Clinical Multicenter Study)[J].中国结合医学杂志（英文版）,2022(01):20-27
A类：
Pai,Neng,panaxadiol,PNDC,andriol,masculinization,hematopathy,disfunction,Registried,ChicTR1900028153
B类：
Treatment,Chronic,Aplastic,Anemia,Chinese,Patent,Medicine,Da,Capsule,Replacing,Androgen,Partially,Clinical,Multicenter,Study,Objective,To,evaluate,efficacy,safety,saponins,component,combination,cyclosporine,androgen,patients,chronic,aplastic,anemia,CAA,Methods,total,was,randomly,divided,into,groups,number,table,including,cases,orally,plus,All,were,treated,followed,treatment,courses,over,weeks,complete,blood,counts,score,medical,CM,symptoms,assessed,urine,routine,electrocardiogram,hepatic,renal,observed,evaluation,Female,rating,scale,established,according,actual,clinical,manifestations,accurate,degree,female,Results,effective,rates,standard,therapeutic,There,difference,white,cell,WBC,platelet,hemoglobin,concentration,peripheral,between,two,after,months,significantly,lower,than,mild,abdominal,distention,In,abnormalities,developed,found,Conclusion,possesses,certain,curative,effects,without,obvious,side,partially,replace,thereby,reduce,Trial,Registry
AB值：
0.471075
相似文献
机标中图分类号，由域田数据科技根据网络公开资料自动分析生成，仅供学习研究参考。
